DE60018759D1 - Anti-ischemischer wirkstoff - Google Patents

Anti-ischemischer wirkstoff

Info

Publication number
DE60018759D1
DE60018759D1 DE60018759T DE60018759T DE60018759D1 DE 60018759 D1 DE60018759 D1 DE 60018759D1 DE 60018759 T DE60018759 T DE 60018759T DE 60018759 T DE60018759 T DE 60018759T DE 60018759 D1 DE60018759 D1 DE 60018759D1
Authority
DE
Germany
Prior art keywords
ischemic
activity
drug
obzidan
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60018759T
Other languages
English (en)
Inventor
Ivan Nikolaevich Tjurenkov
Valentina Mikh Berestovitskaya
Maya Mikhailovna Zobacheva
Olga Sergeevna Vasileva
Nina Vladimirovna Usik
Boris Mikhailovich Novikov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZAKRYTOE AKTSIONERNOE OBSCHESTVO "ASGL-ISSLEDOVATELSKI LABORATORII" ST PETERSBURG
Original Assignee
ZAKRYTOE AKTSIONERNOE OBSCHESTVO "ASGL-ISSLEDOVATELSKI LABORATORII" ST PETERSBURG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZAKRYTOE AKTSIONERNOE OBSCHESTVO "ASGL-ISSLEDOVATELSKI LABORATORII" ST PETERSBURG filed Critical ZAKRYTOE AKTSIONERNOE OBSCHESTVO "ASGL-ISSLEDOVATELSKI LABORATORII" ST PETERSBURG
Application granted granted Critical
Publication of DE60018759D1 publication Critical patent/DE60018759D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Urology & Nephrology (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60018759T 1999-07-21 2000-06-08 Anti-ischemischer wirkstoff Expired - Lifetime DE60018759D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EA199900878A EA002380B1 (ru) 1999-07-21 1999-07-21 Антиишемическое средство
PCT/RU2000/000222 WO2001005399A1 (fr) 1999-07-21 2000-06-08 Agent anti-ischemique

Publications (1)

Publication Number Publication Date
DE60018759D1 true DE60018759D1 (de) 2005-04-21

Family

ID=8161511

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60018759T Expired - Lifetime DE60018759D1 (de) 1999-07-21 2000-06-08 Anti-ischemischer wirkstoff

Country Status (6)

Country Link
EP (1) EP1203585B1 (de)
JP (1) JP2003504404A (de)
AT (1) ATE290909T1 (de)
DE (1) DE60018759D1 (de)
EA (1) EA002380B1 (de)
WO (1) WO2001005399A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2329804C2 (ru) 2006-03-28 2008-07-27 Валентина Ивановна Ахапкина Вещество, обладающее нейротропной - нейромодуляторной активностью
RU2480214C1 (ru) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361882A1 (fr) * 1976-02-11 1978-03-17 Chemisches Lab F W Lang Hydrazides d'acide (2-oxo-pyrrolidino-1)-acetique, procedes pour leur obtention et leur traitement ulterieur et preparations pharmaceutiques qui les contiennent
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
WO1989010354A1 (en) * 1988-04-18 1989-11-02 2 Moskovsky Gosudarstvenny Meditsinsky Institut Im Method for obtaining 4-phenyl-2-pyrrolidone-acetic-1 acid amide
BG49409A1 (en) * 1988-08-15 1991-11-15 Republ N Prakticheski I T Za S Means for food therapy
RU2050851C1 (ru) * 1990-08-28 1995-12-27 Институт медико-биологических проблем Вещество, проявляющее ноотропную активность
EP0632008B1 (de) * 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Pentansäurederivate

Also Published As

Publication number Publication date
EP1203585B1 (de) 2005-03-16
EP1203585A1 (de) 2002-05-08
WO2001005399A1 (fr) 2001-01-25
ATE290909T1 (de) 2005-04-15
EA199900878A1 (ru) 2001-02-26
JP2003504404A (ja) 2003-02-04
EA002380B1 (ru) 2002-04-25
EP1203585A4 (de) 2004-02-04

Similar Documents

Publication Publication Date Title
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
EA200300046A1 (ru) Быстро увеличивающаяся в объеме композиция для удерживания и контролированного выделения терапевтических агентов в желудке и лекарственные формы, включающие композицию
ATE290401T1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
RU2001113688A (ru) Применение паклитаксела, стабилизированного альбумином, для изготовления лекарственного средства для лечения солидных опухолей и лекарственное средство, полученное указанным способом
NO20005912L (no) Sulfonylsyre- eller sulfonylamino-N-(heteroaralkyl)- azaheterocyklylamidforbindelser
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ATE289805T1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
CY1105545T1 (el) Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
ATE290909T1 (de) Anti-ischemischer wirkstoff
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
DE60213234D1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts
DK0559145T3 (da) Lægemiddel til truende abort
DE60327249D1 (de) Anthranilsäureamide und ihre pharmazeutische verwendung
RU97104062A (ru) Применение селегилина для лечения эпилептических заболеваний
DE60007179D1 (de) Pantothensäure-enthaltende arzneimittel zur behandlung von entzündlichen gelenkserkrankungen
RU2005132163A (ru) 2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции
DE60202299D1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
RU2001123675A (ru) Средство бальзам "ГРААЛЬ" для лечения сердечно-сосудистой системы и заболеваний крови человека
TH48579A3 (th) วิธีการของการรักษาโรคเม็ดเลือดแดงที่มีรูปคล้ายเสี้ยวพระจันทร์หรือธาลาสซิเมีย
TH61968A (th) การใช้เมอร์ทาซาพีนเพื่อการรักษาความผิดปกติของการนอนหลับ
BG106025U (en) Medicamentous form

Legal Events

Date Code Title Description
8332 No legal effect for de